Naturhouse Health Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	47.63	49.43	50.41	52.4	57.59
Revenue Growth (YoY)	-3.63%	-1.95%	-3.81%	-9.01%	4.56%
Cost of Revenue	13.36	14.15	13.9	15.16	16.58
Gross Profit	34.27	35.28	36.51	37.24	41.01
Selling, General & Admin	9.25	13.87	12.6	14.62	14.97
Other Operating Expenses	10.64	6.32	5.37	7.48	6.05
Operating Expenses	21.03	22.14	20.23	24.4	23.47
Operating Income	13.24	13.14	16.28	12.84	17.54
Interest Expense	-0.09	-0.6	-0.62	-0.21	-0.1
Interest & Investment Income	-	0.54	0.04	0.11	0.36
Earnings From Equity Investments	0.18	0.47	-0.15	0.31	0.59
Currency Exchange Gain (Loss)	-0.03	-0.03	-0.13	0.04	0.06
Other Non Operating Income (Expenses)	0.49	-	-	-	-
EBT Excluding Unusual Items	13.8	13.53	15.43	13.09	18.45
Gain (Loss) on Sale of Assets	-	0.01	-0.01	0.01	-0.21
Asset Writedown	-0.11	-	-	-	-
Pretax Income	13.7	13.54	15.42	13.1	18.25
Income Tax Expense	3.6	3.68	4.17	3.48	4.88
Earnings From Continuing Operations	10.09	9.86	11.25	9.62	13.37
Minority Interest in Earnings	-	-	0.05	0.01	-0.01
Net Income	10.09	9.86	11.29	9.63	13.36
Net Income to Common	10.09	9.86	11.29	9.63	13.36
Net Income Growth	2.34%	-12.66%	17.30%	-27.95%	42.46%
Shares Outstanding (Basic)	59	60	60	60	60
Shares Outstanding (Diluted)	59	60	60	60	60
Shares Change (YoY)	-0.96%	-	-	-	-
EPS (Basic)	0.17	0.16	0.19	0.16	0.22
EPS (Diluted)	0.17	0.16	0.19	0.16	0.22
EPS Growth	6.25%	-15.06%	17.73%	-27.27%	40.62%
Free Cash Flow	11.67	11.22	20.38	6.13	16.12
Free Cash Flow Per Share	0.20	0.19	0.34	0.10	0.27
Dividend Per Share	-	0.200	-	0.150	0.200
Dividend Growth	-	-	-	-25.00%	233.33%
Gross Margin	71.95%	71.38%	72.42%	71.06%	71.21%
Operating Margin	27.80%	26.58%	32.29%	24.51%	30.46%
Profit Margin	21.19%	19.96%	22.40%	18.37%	23.20%
Free Cash Flow Margin	24.51%	22.70%	40.43%	11.70%	27.99%
EBITDA	14.38	13.52	16.83	13.37	19.86
EBITDA Margin	30.19%	27.36%	33.39%	25.52%	34.48%
D&A For EBITDA	1.14	0.39	0.55	0.53	2.31
EBIT	13.24	13.14	16.28	12.84	17.54
EBIT Margin	27.80%	26.58%	32.29%	24.51%	30.46%
Effective Tax Rate	26.29%	27.17%	27.04%	26.59%	26.74%
Advertising Expenses	-	3.38	2.67	3.5	3.93

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.